perospirone has been researched along with fluoxetine in 1 studies
Studies (perospirone) | Trials (perospirone) | Recent Studies (post-2010) (perospirone) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
---|---|---|---|---|---|
111 | 24 | 26 | 10,100 | 1,663 | 3,263 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katoh, S; Nisijima, K; Shioda, K; Yoshino, T; Yui, K | 1 |
1 other study(ies) available for perospirone and fluoxetine
Article | Year |
---|---|
Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electrochemistry; Fluoxetine; Indoles; Isoindoles; Male; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Wistar; Serotonin Antagonists; Thiazoles | 2004 |